Dr. Gardith Joseph, MD

Dr. Joseph practices at Port Jefferson Station Medical Oncology in Ridge, New York.

Dr. Joseph's NPI, 1811928773, was assigned on July 6, 2006. Dr. Joseph holds New York license 181857.

Dr. Joseph's primary practice is Port Jefferson Station Medical Oncology, at 1 Research Rd, Ridge, NY 11961. The practice phone is (631) 751-3000.

Dr. Joseph's primary practice is Port Jefferson Station Medical Oncology in Ridge, New York. Dr. Joseph is also affiliated with Brookdale Hospital Medical Center. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Joseph to 4 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Joseph practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Joseph's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Joseph is licensed in New York.

CMS data shows 815 Medicare services from Dr. Joseph across 6 procedure codes in 2024, for 114 Medicare patients. Medicare paid $42,118 for them. Every service was in an office.

CMS counts 114 Medicare patients who saw Dr. Joseph in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Joseph's median patient age at 68, with 71% women.

In 2024, Dr. Joseph wrote 2,469 Medicare Part D claims for 236 patients. 70% of them were for generic drugs. CMS names the drug for 2,122 of them, across 51 drugs with 11 or more claims each, at $6,322,882 in total drug cost. In 2023, CMS named 1,911 claims across 47 drugs.

Dr. Joseph accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Joseph as offering telehealth.

Dmand AI links 11 papers to Dr. Joseph, published from 2013 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Janus Kinase 2, Myeloproliferative Disorders and Philadelphia Chromosome. Dr. Joseph has published most often in J Investig Med High Impact Case Rep. Dr. Joseph's most frequent co-authors are Preethi Ramachandran, MD, Lakshmi Boyapati, MD and Anita Pandey, MD.

CMS Open Payments shows 488 general payments to Dr. Joseph from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,514.